Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
The demand for Rx (prescription) adult incontinence products in Turkey experienced robust growth in 2023, driven by a surge in volume sales. Open-tape adult diapers designed for heavy incontinence dominated the market, with the Social Security…
Rising consumer awareness around incontinence and proper condition management, partnerships with direct-to-consumer platforms and the expanding 65+ year-old population in the US all contributed to healthy value and volume growth in the…
Rx/reimbursement adult incontinence in the UK continued to record volume declines in 2023. The category has been in decline for many years in the local market, with consumers shifting towards retail adult incontinence as the availability and…
Value sales of RX/reimbursement adult incontinence products registered moderate growth in 2023. For many people who are embarrassed about incontinence issues, there is a preference to buy incontinence products online, despite insurance reimbursement…
In 2023, Rx/reimbursement adult incontinence recorded moderate volume growth, resulting from growing consumer awareness not only of incontinence, but also from health insurance companies and their reimbursement payments to consumers for the…
An ageing population in need of constant care is driving growth of Rx/reimbursement adult incontinence products in Switzerland among both elderly and temporary post-partum incontinence sufferers. Many Swiss consumers are visiting their doctors more…
In 2023, current value sales of Rx/reimbursement adult incontinence rose substantially due to a spike in unit prices. Although Rx/reimbursement adult incontinence products are available free of charge through Sweden’s public healthcare system, volume…
For nearly 40 years. the Spanish Public Health system has included adult incontinence protection in the list of Rx/reimbursement medical products. These products can be purchased through e-commerce and in health and beauty specialists with the…
The category of Rx/reimbursement adult incontinence experienced growth in both volume and value terms in 2023 in Slovenia, driven primarily by healthcare settings. As the elderly population continues to increase, more individuals are seeking…
The growth of Rx/reimbursement adult incontinence in Slovakia remained stable in 2023, as consumers tend to use these products for a long time. Compared to retail, products prescribed by the doctor are fully reimbursed by an insurance company, and…
Volume sales of Rx/reimbursement adult incontinence in Serbia remained stable in 2023. The ageing population is the main driver of category sales, as the elderly tend to experience incontinence issues later in life. In tandem, rising inflation and…
Unit price points for Rx/reimbursement adult incontinence experienced a high but moderating spike in Norway in 2023. This increase can be attributed to inflationary pressures, including rising input costs such as energy, materials, labour, and…
RX/reimbursement adult incontinence in Lithuania experienced significant growth in 2023, largely driven by state support and legislative changes. The decrease in prices for Rx products by 20-30% from July 1, 2023, provided a substantial boost to…
The demographic landscape in Latvia is undergoing a significant shift, with an increasing proportion of the population comprising elderly individuals. This demographic trend is particularly pronounced among single pensioners who often require…
An ageing population supported continued healthy value and volume growth of Rx/reimbursement adult incontinence in Kazakhstan in 2023. However, with the economy under strain, coupled with the consumer group expanding, the government is considering…
Rx/reimbursement adult incontinence remained in a slump in Italy in 2023, as the government continues to reduce its spending in the healthcare system. In 2024, public expenditure in hospitals and so-called “Community Health Houses” will be further…
Rx/reimbursement adult incontinence saw growth in Israel in 2023. The National Insurance Institute of Israel encourages the elderly to remain at home in their communities. For this reason, it grants long-term care benefits to those who choose to stay…
In 2023, Rx/reimbursement adult incontinence was on the rise in Hungary, fuelled by the ageing population, which led to increased and ongoing use of the products. In a time of rising inflation, consumers were increasingly attracted to reimbursement…
In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a…